NASDAQ: SNTISenti Biosciences Holdings Revenue
Senti Biosciences Holdings revenue was $38.00k for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $16.0k, down 27.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SNTI annual revenue was $22.0k, with Infinity% growth year-over-year.
SNTI past revenue growth
How has SNTI's revenue growth performed historically?
Company
N/A
Industry
245.46%
Market
34.75%
SNTI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SNTI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SNTI revenue history
Current Revenue
$38.0k
Current Earnings
-$51.5M
Current Profit Margin
-135,650%
Be the first to know when SNTI announces revenue.
SNTI Revenue History By Year
| SNTI Yearly Revenue | SNTI Revenue | SNTI Change | SNTI Revenue Growth |
|---|---|---|---|
| 2025-12-31 | $22.00k | N/A | N/A |
| 2024-12-31 | $0.00 | -$2.56M | -100.00% |
| 2023-12-31 | $2.56M | -$1.73M | -40.25% |
| 2022-12-31 | $4.29M | $1.53M | +55.23% |
| 2021-12-31 | $2.76M | $2.20M | +387.81% |
| 2020-12-31 | $566.00k | N/A | N/A |
Senti Biosciences Holdings Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.